FOLH1 as a novel biomarker for risk stratification in gastric intestinal metaplasia

doi:10.3748/wjg.118842

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 25

This Article

(13)

(11)

(0)

(3)

(123)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jul 7, 2026; 32(25): 118842
Published online Jul 7, 2026. doi: 10.3748/wjg.118842

Table 1 Characteristics of patients for digital spatial transcriptomics (n = 8), mean ± SD

Characteristics	N group	P group
Male	2	3
Female	2	1
Age (year)	51.5 ± 9.52	67.25 ± 4.03
GIM
Moderate	2	2
Severe	2	2
OLGIM
Type I	4	4
Helicobacter pylori	2	2

N group: Non-progression group; P group: Progression group; GIM: Gastric intestinal metaplasia; OLGIM: Operative link on gastric intestinal metaplasia.

Full Size Table

Table 2 Characteristics of validation cohort (n = 60), mean ± SD

Characteristics	N1IM	P1IM
Male	17	22
Female	13	8
Age (year)	52.4 ± 12.98	63.97 ± 8.65
GIM
Mild	23	10
Moderate	5	15
Severe	2	5
OLGIM
Type I	26	12
Type II	3	3
Type III	1	15
Helicobacter pylori	16	16

N group: Non-progression group; P group: Progression group; IM: Intestinal metaplasia; GIM: Gastric intestinal metaplasia; OLGIM: Operative link on gastric intestinal metaplasia.

Full Size Table

Citation: He S, Guo XF, Wang Y, Bai JQ, Wang JP, Shi JH, Shi YY, Yuan J, Wei W, Yang Y, Shi XH, Feng Y, Ding X, Gao W, Lu D, Zhou WX, Zhang P. FOLH1 as a novel biomarker for risk stratification in gastric intestinal metaplasia. World J Gastroenterol 2026; 32(25): 118842
URL: https://www.wjgnet.com/1007-9327/full/v32/i25/118842.htm
DOI: https://dx.doi.org/10.3748/wjg.118842

He S, Guo XF, Wang Y, Bai JQ, Wang JP, Shi JH, Shi YY, Yuan J, Wei W, Yang Y, Shi XH, Feng Y, Ding X, Gao W, Lu D, Zhou WX, Zhang P. FOLH1 as a novel biomarker for risk stratification in gastric intestinal metaplasia. World J Gastroenterol 2026; 32(25): 118842 [DOI: 10.3748/wjg.118842]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.